Natixis Advisors
AGN

Natixis Advisors’s Allergan plc AGN Stock Holding History

Natixis Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-121,204
Closed -$21.5M – 1210
2020
Q1 		$21.5M Buy
121,204
+19,604
+19% +$3.69M 0.17% 128
2019
Q4 		$19.4M Buy
101,600
+2,632
+3% +$475K 0.14% 183
2019
Q3 		$16.7M Buy
98,968
+6,045
+7% +$985K 0.13% 183
2019
Q2 		$15.6M Sell
92,923
-9,703
-9% -$1.34M 0.13% 181
2019
Q1 		$15M Buy
102,626
+17,673
+21% +$2.56M 0.13% 173
2018
Q4 		$11.4M Sell
84,953
-20,665
-20% -$3.39M 0.11% 194
2018
Q3 		$20.1M Sell
105,618
-11,849
-10% -$2.18M 0.18% 131
2018
Q2 		$19.6M Buy
117,467
+14,784
+14% +$2.37M 0.19% 118
2018
Q1 		$17.3M Buy
102,683
+26,511
+35% +$4.45M 0.17% 127
2017
Q4 		$12.5M Sell
76,172
-390
-0.5% -$70K 0.13% 193
2017
Q3 		$15.7M Buy
76,562
+875
+1% +$203K 0.17% 138
2017
Q2 		$18.4M Buy
75,687
+1,624
+2% +$382K 0.2% 106
2017
Q1 		$17.7M Buy
74,063
+2,851
+4% +$664K 0.2% 110
2016
Q4 		$15M Buy
71,212
+7,569
+12% +$1.57M 0.18% 138
2016
Q3 		$14.7M Sell
63,643
-13,186
-17% -$3.22M 0.19% 125
2016
Q2 		$17.8M Buy
76,829
+10,706
+16% +$2.47M 0.25% 95
2016
Q1 		$17.7M Sell
66,123
-270
-0.4% -$77.3K 0.27% 79
2015
Q4 		$20.7M Sell
66,393
-1,747
-3% -$520K 0.34% 57
2015
Q3 		$18.5M Buy
68,140
+1,938
+3% +$595K 0.32% 57
2015
Q2 		$20.1M Sell
66,202
-5,031
-7% -$1.5M 0.34% 52
2015
Q1 		$21.2M Buy
71,233
+20,410
+40% +$5.82M 0.37% 38
2014
Q4 		$13.1M Buy
50,823
+7,617
+18% +$1.9M 0.24% 81
2014
Q3 		$10.4M Buy
43,206
+31,838
+280% +$7.13M 0.21% 106
2014
Q2 		$2.54M Sell
11,368
-19,657
-63% -$4.07M 0.04% 607
2014
Q1 		$6.39M Buy
31,025
+2,927
+10% +$580K 0.1% 344
2013
Q4 		$4.72M Buy
28,098
+26,411
+1,566% +$4.13M 0.08% 413
2013
Q3 		$243K Buy
+1,687
New +$225K ﹤0.01% 1032

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Natixis Advisors's AGN Position: Q2 2020 in Review

Natixis Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 121,204 shares — an estimated $21.5M sold.

Natixis Advisors first reported a position in AGN in Q3 2013 and held it in 27 quarters. The position peaked at $21.5M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Natixis Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Natixis Advisors sold 121,204 Allergan plc shares in Q2 2020, an estimated $21.5M.
  • Natixis Advisors first reported a position in Allergan plc in Q3 2013 and held it in 27 quarters.
  • Natixis Advisors's Allergan plc position peaked at $21.5M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Natixis Advisors's 13F filing for Q2 2020, filed 11 Aug 2020.